Reassessing the Luteinizing Hormone/Follicle-Stimulating Hormone Ratio in Polycystic Ovary Syndrome: Associations With a Possible Neuroendocrine and Anti-Müllerian Hormone-Related Phenotype.

Abstract excerpt

PURPOSE: To comprehensively reassess the clinical and metabolic significance of the luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio in women with polycystic ovary syndrome (PCOS), and to investigate whether it is associated with a clinical and hormonal pattern consistent with a possible neuroendocrine-dominant subgroup, distinguishable from insulin-related metabolic presentation. DESIGN:...

Topics

• Humans
• Female
• Polycystic Ovary Syndrome
• Anti-Mullerian Hormone
• Luteinizing Hormone